только для медицинских специалистов
Консультант врача. Электронная медицинская библиотека

Консультант врача

Электронная медицинская библиотека

Доступ к библиотеке Версия для слабовидящих
Раздел 4 / 4
Страница 1 / 1

Литература

  1. Travis S.P., Dinesen L. Remission in trials of ulcerative colitis: what does it mean? // Pract. Gastroenterol. - 2010. - Vol. 30. - Р. 17-20.
  2. D' Haens G. et а!. А review of activity indices and efficacy end points for clini­ cal trials of medical therapy in adults with ulcerative colitis // Gastroenterology. - 2007. - Vol. 132. - Р. 763-786.
  3. Cosnes J., Gower-Rousseau С., Seksik Р., Cortot А. Epidemiology and nat­ ural blstory of inflammatory bowel diseases // Gastroenterology. - 2011. - Vol. 140. - Р. 1785-1794.
  4. Katsanos К.Н., Vermeire S., Christodoulou D.К. et а!. Dysplasia and cancer in infiammatory bowel disease 10 years after diagnosis: results of а population-based Eu­ ropean collaborative follow-up study // Digestion. - 2007. - Vol. 75. - Р. 113-121.
  5. Silverberg M.S., Satsangi J., Ahmad Т. et а!. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of а Working Party of the 2005 Montreal World Congress of Gastroenterology // Can. J. Gastroenterol. - 2005. - Vol. 19, suppl. А. - Р. 5-36.
  6. Truelove S. С. et а!. Cortisone in ulcerative colitis; final report on а therapeutic trial / / Br. Med. J. - 1955. - Vol. 2. - Р. 1041-1048.
  7. Seah D., Cruz Р De. Review article: the practical management of acute severe ulcerative colitis // Aliment. Pharmacol. Тher. - 2016. - Vol. 43, N 4. - Р. 482-513.
  8. Hindryckx Р., Jairath V., D'Haens G. Acute severe ulcerative colitis: from patho­ physiology to clinical management // Nat. Rev. Gastroenterol. Hepatol. - 2016. - Vol. 13, N 11. Р. 654-664.
  9. Chen J.Н., Andrews J.M, Kariyawasam V., Moran N IBD Sydney Organisation and the Australian Infiammatory Bowel Diseases Consensus Working Group. Re­ view article: acute severe ulcerative colitis - evidence-based consensus statements // Aliment. Pharmacol. Ther. - 2016. - Vol. 44, N 2. - Р. 127-144.
  10. Schroeder К.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: А randomized study // N. Engl. Med. - 1987. - Vol. 317. - Р. 1625-1629.
  11. Григорьева Г.А., Мешалкина Н.Ю. О проблеме системных проявлений воспалительных заболеваний кишечника// Фарматека. - 2011. - № 15. - с. 44-49.
  12. lssa М., Vikayapal А., Gracham МВ. et а!. lmpact of Clostridium difficile in inflammatory bowel disease patients // Clin. Gastroenterol. Hepatol. - 2007. - Vol. 5. - Р. 345- 351.
  13. Rodeman J.F., Dubberke E.R., Reske К.А. et а!. Incidence of Clostridium difficile iп inflammatory bowel disease // Clin. Gastroenterol. Hepatol.- 2007. - Vol. 5. - Р. 339-344.
  14. Jssa М., Ananthakrishnan A.N., Binion D.G. Clostridium difficile and inflam­ matory bowel disease // Inflamm. Bowel Dis. - 2008. - Vol. 14. - Р. 1432-1442.
  15. Nguyen G.C., Kaplan G.G., Harris M.L. et а!. А national sшvey ofthe preva­ lence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patieпts // Ат. J. Gastroenterol. - 2008. - Vol. 103. - Р. 1443- 1450.
  16. Mindenmark М., Larsson А. Rulling out IBD estimation of the possiЫe eco­ nomic effects of pre-endoscopic screening with F-calprotectin // Clin. Biochem. - 2012. - Vol. 45. - Р. 552-555.
  17. Costa F., Mumolo М. G., Bellini М. et а!. Role of faecal calprotectin as non­ invasive marker of intestinal inflammation // Dig. Liver Dis. - 2003. - Vol. 35. - Р. 642-647.
  18. Корнеева О.И., Ивашкин В.Т. Антибиотикоассоциированный колит: патоморфология, клиника, лечение// Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2007.-:- Т. 17, No 3. - С. 65-71.
  19. Ивашкин В.Т., Шептулин А.А., Шифрин О.С. и др. Микроскопический колит: клинические формы, диагностика, лечение // Рос. журн. гастроэнтерол., гепатол., колопро ктол. - 2006. - Т. 16, No 6. - С. 56-60.
  20. Белоусова Е.А., Никитина Н.В., Цодикова 0.М. Лечение язвенного колита легкого и среднетяжелого течения// Фарматека. - 2013. - No 2. - С. 42-46.
  21. Халиф И.Л. Лечебная тактика при язвенном колите// Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2006. - Т. 16, No 3. - С. 58-62.
  22. Dignass А. et а!. Second EUROPEAN evidence-based consensus on the diagnosis and management of ulcerative colitis: Current management / / J. Crohns Colitis. - 2012. - Vol. 6, N 10. - Р. 991-1030.
  23. Халиф И.Л. Принципы лечения язвенного колита (рекомендации Российской группы по изучению воспалительных заболеваний кmпеtП1ИКа) / / Колопроктология. -2006. -№ 2. -С. 31-33.
  24. Su С., Lewis J.D., Goldberg В. et а!. А meta-analysis ofthe placebo rates of remission and response in clinical trials of active ulcerative colitis // Gastroenterol­ ogy. - 2007. - Vol. 132. - Р. 516- 526.
  25. Marshall J.K., ТhаЬапе М, Steinhart А.Н. et а!. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis // Cochrane Database Syst. Rev. - 2010. - Vol. 1. [CD004115-CD004115].
  26. Marshall J.K, Irvine E.J. Rectal corticosteroids versus alternative treatments in ulcerative colitis: а meta-analysis // Gut. - 1997. - Vol. 40. - Р. 775- 781.
  27. Lamet М. А multicenter, randornized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg twice daily in patients with active mild-to-moderate ulcerative proctitis // Dig. Dis. Sci. - 2011. - Vol. 56. - Р. 513-522.
  28. Safdi М., DeMicco М., Sninsky С. et а!. А douЫe-Ыind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ul­ cerative colitis // Ат. 1. Gastroenterol. - 1997. - Vol. 92. - Р. 1867-1871.
  29. Sutherland L., Macdonald J.K. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis // Cochrane Database Syst. Rev. - 2006. - Vol. 2. [CD000543].
  30. Regueiro М., Loftus Jr Е.V., Steinhart А.Н., Cohen R.D. Medical management ofleft-sided ulcerative colitis and ulcerative proctitis: critical evaluation oftherapeu­ tic trials // Inflamm. Bowel Dis. - 2006. - Vol. 12. - Р. 979-994.
  31. Ford А.С., Achkar J.-P., Khan K.J. et а!. Eflicacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis // Ат. J. Gastroenterol. - 2011. - Vol. 106. - Р. 601-616.
  32. Капе S.V., Bjorkman D.J. The eflicacy of oral 5-ASAs in the treatment of ac­ tive ulcerative colitis: а systematic review // Rev. Gastroenterol. Disord. - 2003. - Vol. 3. - Р. 210-218.
  33. Lichtenstein G.R. Budesonide multi-matrix for the treatment ofpatients with ulcerative colitis // Dig. Dis. Sci. - 2016. - Vol. 61, N 2. - Р. 358-370.
  34. Sherlock М.Е., MacDonald J.K., Griffiths А.М. et а!. Oral budesonide for induction of remission in ulcerative colitis // Cochrane Database Syst. Re_v·. 2015. - Vol. 10. [CD007698].
  35. Danese S., Siegel С.А., Peyrin-Biroulet L. Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis // Aliment. Pharmacol. Ther. - 2014. - Vol. 39, N 10. - Р. 1095-1103.
  36. Gisbert J.P., Linares Р.М., McNichollA.G. et al. Meta-analysis: the eflicacy of azatbloprine and mercaptopurine in ulcerative colitis // Aliment. Pharmacol. Ther. - 200_9. · Vol. 30. - Р. 126-137.
  37. Colombel J.F., Sandborn WJ., Reinisch W et а!. Infliximab, azatbloprine, or combination therapy for Crohn's disease // N. Engl. J. Med. - 2010. - Vol. 362, N 15. - Р. 1383-1395.
  38. Yarur A.J., Rubln D.Т. Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases / / Inflamm. Bowel Dis. - 2015. - Vol. 21, N 7. - Р. 1709-1718.
  39. Steenholdt С., Bendtzen К, Brynskov J., Ainsworth М.А. Optimizing treat­ ment with TNF inblЬitors in inflammatory bowel disease Ьу monitoring drug levels and antidrug antibodies // Inflamm. Bowel Dis. - 2016. - Vol. 22(8) , Aug. - Р. 1999-2015.
  40. Panaccione R., Ghosh S., Middleton S. et а!. Jnfiiximab, azathioprine or inflix­ imab + azathioprine for treatment of moderate to severe ulcerative colitis. The UC SUCCESS trial // J. Crohns Colitis. - 2011. - Vol. 5. - Р. 13.
  41. Gonzalez-Huix F., Fernandez-Banares F., Esteve-Comas М. et а!. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis // Ат. J. Gastroenterol. - 1993. - Vol. 88. - Р. 227-232.
  42. Кhап KJ., Ullman Т.А., Ford А.С. et а!. AntiЬiotic therapy in inflammatory bowel disease: а systematic review and meta-analysis // Ат. J. Gastroenterol. - 2011. - Vol. 106. - Р. 661-673.
  43. Ohkusa Т., Kato К., Terao S. et а!. Newly developed antiЬiotic combination therapy for ulcerative colitis: а douЫe-blind placebo-controlled multicenter trial // Ат. J. Gastroenterol. - 2010. - Vol. 105. - Р. 1820- 1829.
  44. Gionchetti Р., Rizzello F., Ferrieri А. et а!. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: а dou Ьle-Ыind, placebo­ controlled trial // Dig. Dis. Sci. - 1999. - Vol. 44, N 6. - Р. 1220- 1221.
  45. Frey В.М, Frey EJ. Clinical pharmacokinetics ofprednisone and predniso­ lone // Clin. Pharmacokinet. - 1990. - Vol. 19, N 2. - Р. 126-146.
  46. Thmer D. Response to corticosteroids in severe ulcerative colitis: а systematic review ofthe literature and а meta-regression // Clin. Gastroenterol. Hepatol. - 2007. - Vol. 5, N 1. - Р. 103-110.
  47. Jiimerot G., Hertervig Е., Friis-Liby I et а!. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: а randomized, placebo-controlled study // Gastroenterology. - 2005. - Vol. 128. - Р. 1805-1811.
  48. Lees С.W, Heys D., Но G.Т. et а!. А retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis// Aliment. Pharmacol. Ther. - 2007. - Vol. 26. - Р. 411-419.
  49. Assche G. van, D'Haens G., Noman М. et а!. Randomized, douЫe-Ыind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis // Gastroenterology. - 2003. - Vol. 125. - Р. 1025-1031.
  50. Sjoberg М., Walch А., Meshkat М. et а/. Infliximab or cyclosporine as res­ cue therapy in hospitalized patients with steroid-refractory ulcerative colitis: а retrospective observational study // Inflamm. Bowel Dis. - 2012. - Vol. 18, N 2. - Р. 212-218.
  51. Sokol Н., Seksik Р., Carrat Е et а/. Usefulness of co-treatment with irnmu­ nomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy // Gut. - 2010. - Vol. 59. - Р. 1363-1368.
  52. Reinisch W., Sandbom WJ., Rutgeerts Р. et а/. Long-term infliximab mainte­ nance therapy for ulcerative colitis: the АСТ-1 and -2 extension studies // Inflamm. Bowel Dis. - 2012. - Vol. 18. - Р. 201-211.
  53. CheЫi L.A., Chaves L.D., Pimentel ЕЕ et а/. Azatbloprine maintains long­ term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis // Infiamm. Bowel Dis. - 2010. - Vol. 16. - Р. 613-619.
  54. Randall J.S.B., Warren В.Е, Travis S.P. et а/. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications / / Br. J. Surg. - 2010. - Vol. 97. - Р. 404-409.
  55. Lennard-Jones J.E., Ritchie J.K, Hilder W, Spicer С.С. Assessment of severity in colitis: а preliminary study // Gut. - 1975. - Vol. 16. - Р. 579-584.
  56. Travis S.P., Farrant J.М., Ricketts С. et а!. Predicting outcome in severe ulcer­ ative colitis // Gut. - 1996. - Vol. 38. - Р. 905-910.
  57. Lindgren S.C., Flood L.М., Kilander А.Е et а!. Early predictors of glucocor­ ticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis // Eur. J. Gastroenterol. Hepatol. - 1998. - Vol. 10. - Р. 831-835.
  58. Benauato L., D'/пса R., Grigoletto Е et а!. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment // Dig. Liver Dis. - 2004. - Vol. 36. - Р. 461-466.
  59. Almer S., Bodemar G., Franzen L. et а/. Use of air enema radiographyto assess depth of ulceration during acute attacks of ulcerative colitis // Lancet. - 1996. - Vol. 347. - Р. 1731-1735.
  60. Carbonnel Е, Lavergne А., Lemann М. et а/. Colonoscopy of acute colitis. Аsafe and reliaЫe tool for assessment of severity // Dig. Dis. Sci. - 1994. - Vol. 39. - Р.1550-1557.
  61. Ferrante М., Vermeire S., Katsanos К.Н. Predictors of early response to inflix­ imab in patients with ulcemtive colitis // Inflamm. Bowel D is. - 2по1. - Vol. 13, N 2. - Р. 123-128.
  62. Gonza/ez-Lama У., Fernandez-B/anco 1., Lopez-SanRoman А. Open-label infliximab therapy in ulcerative colitis: а multicenter survey of results and pre­ dictors of response // Hepatogastroenterology. - 2008. - Vol. 55, N 86-87. - Р. 1609-1614.
  63. Fasanmade А.А., Adedokun O.J., O/son А. et а/. Serum albumin concentra­ tion: а predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis // Int. Clin. Pharmacol. Ther. - 2010. - Vol. 48, N 5. - Р. 297-308.
  64. Oussa/ah А., Evesque L., Lahari.e D., RoЬ/in ХА multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimiz.ation, colectomy, and hospitalization // Ат. J. Gastroenterol. - 2010. - Vol. 105, N 12. - Р. 2617-2625.
  65. Головенко А.О., Халиф И.Л., Головенко О.В., Веселов В.В. Предикторы эффективности инфликсимаба у больных с тяжелой атакой язвенного коли­ та// Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2013. - № 3. - С. 65-73.
  66. Cacheux W., Seksik Р., Lemann М. et а/. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis // Ат. J. Gastroenterol. - 2008. - Vol. 103, N 3. - Р. 637-642.
  67. Monterubblanesi R., Aratari А., Armuzzi А. et а/. Infliximab three-dose in­ duction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy// J. Crohns Colitis. - 2014. - Vol. 8, N 8. - Р. 852-858.
  68. Ardizzone S., Maconi G., Russo А. et а/. Randomised controlled trial of aza­ tbloprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis // Gut. - 2006. - Vol. 55. - Р. 47-53.
  69. Gan S.I, Beck P.L. А new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management / / Ат. J. Gastroenterol. - 2003. - Vol. 98. - Р. 2363-2371.
  70. Eaden J.A., Abrams К.R., Mayberryl.F. The riskof colorectal cancerin ulcer­ ative colitis: а meta-analysis // Gut. - 2001. - Vol. 48. - Р. 526-35.
  71. Jess Т., Loftus Jr Е.V., Velayos F.S. et а/. Risk of intestinal cancer in infiam­ matory bowel disease: а population-based study from olmsted county, Мinnesota // Gastroenterology. - 2006. - Vol. 130. - Р. 1039-1046.
  72. Bergeron V., Vienne А., Sokol Н. et а/. Risk factors for neoplasia in inflamma­ tory bowel disease patients with pancolitis // Am. J. Gastroenterol. - 2010. - Vol. 105, N 11. Р. 2405-2411.
  73. Rutter М., Saunders В., Wilkinson К. et а/. Severity of infiammation is а risk factor for colorectal neoplasia in ulcerative colitis // Gastroenterology. - 2004. - Vol. 126. - Р. 451-459.
  74. Справочник по колопроктологии / Под ред. Ю.А. Шелыгина, Л.А. Благодарного.- М.: Липерра, 2012. - С. 460-522.
  75. &chards D.M., Hughes S.A., Irving МН., Scott N.A. Patient quality of life after successful restorative proctocolectomy is norrnal // Colorectal Dis. - 2001. - Vol. 3. - Р. 223-226.
  76. McLaughlin S. D., Clark S.К., Thomas-Gibson S. et а/. Guide to endoscopy of the ileo-anal pouch following restorative proctocolectomy witl1 ileal pouch-anal anastomosis; in dicat io пs , techпique, апd management of commoп findings // Inftamm. Bowel Dis. - 2009. - Vol. 15. - Р. 1256-1263.
  77. Berndtsson /., Oresland Т. Quality oflife before апd after proctocolectomy and IPAA in patients with ulcerative proctocolitis - а prospective study // Colorectal Dis. - 2003. - Vol. 5. - Р. 173-179.
  78. Marce/lo Р. W , Roberts P.L., Schoetz Jr D.J. et а/. Long-term results of the ileoanal pouch procedure // Arch. Surg. - 1993. - Vol. 128. - Р. 500-503 [dis­ cussion 503-504].
  79. Sagar Р.М., РетЬе,1оп J.Н. Ileo-anal pouch function and dysfunction / / Dig. Dis. - 1997. - Vol. 15. - Р. 172-188.
  80. Meagher А. Р., Farouk R., Dozois R.R. et а/. J ileal pouch-anal anastomosis for cl1ronic ulcerative colitis: complications and long-term outcome in 1310 patients // Br. J. Surg. - 1998. - Vol. 85. - Р. 800-803.
  81. Setti-Carraro Р., Ritchie J.К., Wilkinson К.Н. et а/. The first 10 years' experi­ ence of restorative proctocolectomy for ulcerative colitis // Gut. - 1994. - Vol. 35. - Р. 1070-1075.
  82. Fazio V.W, Ziv У., Church J.M. et а/. Ileal pouch-anal anastomoses com­ plications and function in 1005 patients // Ann. Surg. - 1995. - Vol. 222. - Р. 120-127.
  83. Belliveau Р., Trudel J., Vasilevsky С.А. et а/. Ileoanal anastomosis with reser­ voirs: complications and long-term results // Can. J. Surg. - 1999. - Vol. 42. - Р. 345-352.
  84. Pinto R.A., Canedo J., Murad-Regadas S. et а/. Леаl pouch-anal anastomosis in elderly patients: is there а difference in morЬidity compared with younger pa­ tients? // Colorectal Dis. - 2011. - Vol. 13. - Р. 177-183.
  85. Church J.M. Functional outcome and quality of life in an elderly patient with an ileal pouch-anal anastomosis: а 10-year follow up // Aust. N.Z. J. Surg. - 2000. - Vol. 70. - Р. 906-907.
  86. Chapman J.R., Larson D.W, Wolff В.G. et а/. Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome? // Arch. Surg. - 2005. - Vol. 140. - Р. 534-540.
  87. Delaney С.Р., Dadvand В., Remzi F.Н. et а/. Functional outcome , quality of life, and complications after ileal pouch-anal anastomosis in selected septuagenar­ ians // Dis. Colon Rectum. - 2002. - Vol. 45. - Р. 890-894.
  88. O/sen К.О., Joelsson М., Laurberg S., Oresland Т. Fertility after ileal pouch­ anal anastomosis in women with ulcerative colitis / / Br. J. Surg. - 1999. - Vol. 86. - Р. 493-495.
  89. Ording О.К., Juul S., Berndtsson /. et а/. Ulcerative colitis: female fecundity before diagnosis, during disease , and after surgery compared with а population sample // Gastroenterology. - 2002. - Vol. 122. - Р. 15-19.
  90. Gorgun Е., Remzi F.H ., Goldberg J.M. et а/. Fertility is reduced after restor­ ative proctocolectomy with iJeal pouch anal anastomosis: а study of 300 patients // Surgery. - 2004. - Vol. 136. - Р. 795-803.
  91. Johnson Р., Richard С., Ravid А. et а/. Female infertility after ileal poucl1-anal aпastomosis for ulcerative colitis // Dis. Colon Rectum. - 2004. - Vol. 47. - Р. 1119-1126.
  92. Oresland Т., Ра/тЬ/аd S., Ellstrom М. et а/. Gynaecological and sexual func­ tion related to anatomical changes in the female pelvis after restorative proctocolec­ tomy // lnt. J. Colorectal Dis. - 1994. - Vol. 9. - Р. 77-81.
  93. Alves А., Panis У., Bouhnik У. et а/. Subtotal colectomy for severe acute colitis: а 20-year experience of а tertiary care center with an aggressive and early surgical policy // J. Am. Coll. Surg. - 2003. - Vol. 197. - Р. 379-385.
  94. Berg D.F., Bahadursingh А.М., Kaminski D.L., Longo W.E. Acute surgical emergencies in inflammatory bowel disease // Ат. J. Surg. - 2002. - Vol. 184. - Р. 45-51.
  95. Нутап N.H., Cataldo Р., Osler Т. Urgent suЬtotal colectomy for severe in­ flammatorybowel disease // Dis. Colon Rectum. - 2005. - Vol. 48. - Р. 70-73.
  96. Holubar S.D., Larson D.W., Dozois E.J. et а/. Minimally invasive suЬtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: а rea­ sonaЫe approach? // Dis. Colon Rectum. - 2009. - Vol. 52. - Р. 187-192.
  97. Marceau С., Alves А., Ouaissi М. et а/. Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: а case-matched study in 88 patients // Surgery. - 2007. - Vol. 141. - Р. 640.
  98. Annibali R., Oresland Т., Hulten L. Does the level of stapled ileoanal anas­ tomosis influence physiologic and functional outcome? // Dis. Colon Rectum. - 1994. - Vol. 37. -Р. 321-329.
  99. Burns Е.М., Bottle А., Aylin Р. et а/.. Volume analysis of outcome following restorative proctocolectomy // Br. J. Surg. - 2011. - Vol. 98. - Р. 408-417.
  100. Tekkis Р.Р., Fazio V.W., Lavery 1.С. et а/. Evaluation of the learning curve in ileal pouch-anal anastomosis surgery // Ann. Surg. - 2005. - Vol. 241. - Р. 262-268.
  101. Lepisto А. et а/. Fate of the rectum after colectomy with ileorectal anastomo­ sis in ulcerative colitis // Scand. J. Surg. - 2005. - Vol. 94. - Р. 40-42.
  102. Edwards С.М., George В., Warren B.F. Diversion colitis: new light through old windows // Histopathology. - 1999. - Vol. 335, N 1. - Р. 86-87.
  103. Shepherd N.A., Jass J.R., Duval 1. et а/. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal Ьiopsy speci­ mens // J. Clin. Pathol. - 1987. - Vol. 40. - Р. 601-607.
  104. Setti Carraro P.G., Talbot 1.С., Nicholls J.R. Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative procto­ colectomy for ulcerative colitis. А long-term follow-up study // Int. J. Colorectal Dis. - 1998. - Vol. 13. - Р. 103-107.
  105. Ferrante М, D,Hoore А., Vermeire S. et а/. Corticosteroids but not infiiximab increase short-term postoperative infectious complications in patients with ulcer­ ative colitis // Inflamm. Bowel Dis. - 2009. - Vol. 15. - Р. 1062-1070.
  106. Lake J.P., Firoozmand Е., Kang J.C. et а/. Effect of high-dose steroids on anastomotic complications after proctocolectomy with ileal pouch-anal anasto­ mosis // J. Gastrointest. Surg. - 2004. - Vol. 8. - Р. 547-551.
  107. Mahadevan И., Loftus Jr Е.V., Tremaine WJ. et а/. Azathioprine or 6-mer­ captopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications // Inflamm. Bowel Dis. - 2002. - Vol. 8. - Р. 311-316.
  108. Pugliese D., Armuzz.i А., Rizz.o G. et а/. Effect of anti-TNF-alpha treatment on short-term post-operative complications in patients with inflammatory bowel disease // Gut. - 2010. - Vol. 59, suppl. 11. - Р. АlЗ.
  109. Sub,·amanian V., Pollok R. C., Kang J.У., Kumar D. Systematic review ofpost­ operative complications in patients with infiammatory bowel disease treated with immunomodulators // Br. J. Surg. - 2006. - Vol. 93. - Р. 793- 799.
  110. Yang Z., Wu Q., Wang F. et а!. Meta-analysis: effect of preoperative infiix­ imab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery // Aliment. Pharmacol. Ther. - 2012. - Yol. 36, N 10. - Р. 922-928.
  111. Simchuk E.J., Thirlby R. С. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses // World J. Surg. - 2000. - Vol. 24. - Р. 851-856.
  112. Stahlberg D., Gullberg К., Liljeqvist L. et а!. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors / / Dis. Colon Rectum. - 1996. - Vol. 39. - Р. 1012-1018.
  113. Реппа С., Тiret Е., Kartheuser А. et а!. Function of ileal J pouch-anal anas­ tomosis in patients with familial adenomatous polyposis // Br. J. Surg. - 1993. - Vol. 80. - Р. 765-767.
  114. Т}andra J.J., Fazio V.W., Church J.M. et а!. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis // Ат. J. Surg. - 1993. - Vol. 165. - Р. 322-325.
  115. Shen В., AchkarJ.P., Lashner В.А. IпitaЫe pouch syndrome: а new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis // Ат. J. Gastroenterol. - 2002. - Vol. 97, N 4. - Р. 972-977.
  116. Arnerican Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: controlling tuberculosis in the United States // Ат. J. Respir. Crit. Саге Med. - 2005. - Vol. 172, N 9. - Р. 1169-1227.
  117. ОСЕВМ Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. - URL: http://www.cebm. net/ocebm-levels-of-evidence.

Для продолжения работы требуется вход / регистрация